I know it sounds silly, but with the pipeline here, this shouldn't go down much if there was a failure with ICT-107 when comparing to preclinical $230 million mc VSTM
Sentiment: Strong Sell
UH-OH, sounds like the acolytes are preparing us for some bad results.
By the way, WHAT PIPELINE??????????
This should trade 400-500 million mc 'before' results and $1.5+ billion 'if' the results are good, as this is the leading cancer stem cell immunotherapy company and biotechs typically trade at a 4-8 p/s ratio